Annexon, Inc.
NASDAQ:ANNXBiotechnology
-$0.04 today
- Market cap
- $576.73M
- Beta
- 1.18
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.01
Volume 2.98M
Average 2.56M
ANNX Total Debt
Short-term and long-term borrowings combined.
Annexon, Inc.NASDAQ: ANNX
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt falls 10.2% from a year ago
Total debt stood at $25.43M at the end of Q1 FY2026, down 10.2% from a year earlier and down 2.9% from the prior quarter. Over 3 fiscal years it compounded at -7.3% a year.
Context
- Total debt amounted to 9.7% of total assets at the end of Q1 FY2026, up 0.3 pp from a year earlier.
- Total debt increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -10.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 26.2M USD
- Year-over-year change
- -9.6%
- 4-year CAGR
- -6.7%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.2M | -9.6% |
| FY2024 | 2024-12-31 | 28.97M | -7.6% |
| FY2023 | 2023-12-31 | 31.36M | -4.6% |
| FY2022 | 2022-12-31 | 32.86M | -5.0% |
| FY2021 | 2021-12-31 | 34.59M | — |
Total Debt vs competitors
How ANNX compares with its peers on the latest reported figures
- Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -10.2% is the 5th highest of 10, against a peer median of -16.8%.
- Total debt amounts to 9.7% of total assets for ANNX, versus a peer median of 2.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $277.36M USD | +1680.8% | -10.1% | 84.1% | |
| Jun 2026 | $65.21M USD | -4.0% | +46.6% | 9.0% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $36.43M USD | -6.1% | +174.8% | 6.5% |
| Mar 2026 | $25.43M USD | -10.2% | -7.3% | 9.7% | |
| Mar 2026 | $10.99M USD | -41.5% | -30.0% | 17.3% | |
| Mar 2026 | $7.65M USD | -25.0% | +28.9% | 2.2% | |
| Mar 2026 | CHF 4.3M CHF | -16.8% | +17.5% | 3.1% | |
| Mar 2026 | $1.99M USD | -20.1% | +45.7% | 1.0% | |
| Jun 2026 | €1.21M EUR | -98.6% | +5.4% | 0.3% | |
| Mar 2026 | €823.89K EUR | +17.3% | -12.9% | 1.7% | |
| Sep 2026 | $0 USD | — | -61.1% | 0.0% | |
| Peer median (excluding ANNX) | — | -16.8% | +11.5% | 2.7% | |
Competitors are the stored peer set for ANNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 74.84M | 140.02M | 225.11M | 49.5M | 162.05M |
| Short-term Investments | 167.87M | 102.64M | 34.61M | 262.52M | 76.29M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 463K | 203K | 63K | 1.1M | 1.24M |
| Total Current Assets | 247.69M | 248.1M | 263.86M | 316.46M | 242.19M |
| Property, Plant & Equipment (Net) | 38.18M | 35.97M | 32.78M | 29.34M | 25.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 1.03M | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.17M | 1.03M | 1.03M | 4.27M | 9.58M |
| Total Non-current Assets | 39.35M | 37M | 33.81M | 33.61M | 35.38M |
| Total Assets | 287.04M | 285.1M | 297.67M | 350.07M | 277.57M |
| Account Payables | 11.15M | 7.42M | 5.49M | 10.43M | 14.93M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.06M | 180K | 5.65M | 5.97M | 8.03M |
| Total Current Liabilities | 21.74M | 22.36M | 17.93M | 30.51M | 42.63M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 33.39M | 31.54M | 29.19M | 26.45M | 23.29M |
| Total Liabilities | 55.13M | 53.9M | 47.12M | 56.97M | 65.92M |
| Common Stock | 39K | 48K | 78K | 109K | 149K |
| Retained Earnings | (296.32M) | (438.26M) | (572.5M) | (710.7M) | (917.39M) |
| Accumulated OCI | (180K) | (372K) | (52K) | 10K | (29K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 231.91M | 231.19M | 250.56M | 293.11M | 211.65M |
| Total Debt | 34.59M | 32.86M | 31.36M | 28.97M | 26.2M |
| Net Debt | (40.25M) | (107.16M) | (193.76M) | (20.53M) | (135.85M) |
Annexon, Inc.
NASDAQ:ANNX
Intrinsic Alpha fair value
Locked
Current Price
$3.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.